REALM - RANDOMIZED, OBSERVATIONAL STUDY OF ENTECAVIR TO ASSESS LONG-TERM OUTCOMES ASSOCIATED WITH NUCLEOSIDE/NUCLEOTIDE MONOTHERAPY FOR PATIENTS WITH CHRONIC HIV INFECTION
Mark Identification

REALM - RANDOMIZED, OBSERVATIONAL STUDY OF ENTECAVIR TO ASSESS LONG-TERM OUTCOMES ASSOCIATED WITH NUCLEOSIDE/NUCLEOTIDE MONOTHERAPY FOR PATIENTS WITH CHRONIC HIV INFECTION

Serial Number

85041166

Filing Date

May 18, 2010

Trademark by

BRISTOL-MYERS SQUIBB COMPANY

Classification Information

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Computer and Scientific